What Caught Our Attention in the Investment World? – Week of October 10-14, 2022

By Kuldip K. Ambastha The stock of BeiGene, Ltd. (BGNE), a commercial stage biopharmaceutical company focused on cancer treatment drugs, saw a +20.5% increase in price per share on Wednesday, October 12, 2022. Brukinsa (zanubrutinib) in its Phase 3 trial data showed highly positive results in people with chronic lymphocytic leukemia (CLL) or small lymphocytic …

What Caught Our Attention in the Investment World? – Week of September 6-9, 2022

By Kuldip K. Ambastha The stock of Regeneron Pharmaceuticals, Inc. (REGN), a biotechnology company with a portfolio of medicines for individuals with serious diseases, increased in price by +18.8% per share on the trading day of Thursday, September 8, 2022. Eylea (aka: aflibercept), an anti-blindness eye medication, was the cause of this price run-up, because …

What Caught Our Attention in the Investment World? – Week of March 28-April 1, 2022

By Kuldip K. Ambastha Longeveron Inc. (LGVN), a biotechnology company focused on clinical stage therapies, had its stock price rise by +105.4% per share on Thursday, March 31, 2022. On this trading day, a great piece of news led to a great return. Lomecel-B has shown positive results from its Phase 1 trial testing on …

What Caught Our Attention in the Investment World? – Week of January 31-February 4, 2022

By Kuldip K. Ambastha Alphabet Inc. (GOOG), the parent company of Google, was a star performer on Wednesday February 2, 2022 when its stock delivered a +7.4% return for the trading day. The company’s earnings and revenue figures for the latest reporting quarter exceeded expectations. Furthermore, the company also announced a 20-for-1 stock split which …

What Caught Our Attention in the Investment World? – Week of August 30-September 3, 2021

By Kuldip K. Ambastha On Friday, September 3, 2021, the stock of Forte Biosciences, Inc. (FBRX) stood out for its substantial trading day loss of -82.3%. Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on potential treatments for inflammatory skin diseases. The company released results of a Phase 2 clinical trial of FB-401, related …

What Caught Our Attention in the Investment World? – Week of June 7-11, 2021

By Kuldip K. Ambastha Biogen Inc. (BIIB), a biotech company, had a memorable Monday of this past trading week. On Monday, June 7, 2021, Biogen had a +38.3% gain for the day on its stock. Biogen’s Alzheimer’s disease treatment was approved by the U.S. Food and Drug Administration (FDA) as part of an accelerated approval …

What Caught Our Attention in the Investment World? – Week of August 24 – 28, 2020

By Kuldip K. Ambastha On Wednesday, August 26, 2020, the stock of Salesforce.com, Inc. (CRM) had a pop of 26.0%. The stock posted smaller positive and negative returns during other days of the trading week. Strong 2Q2020 results drove the 26.0% gain in one day. For the first time, in 2Q2020 Salesforce.com, Inc. had more …

Dow Jones Index Volatility – Week of June 8 – 12, 2020

By Kuldip K. Ambastha The Dow Jones Industrial Average (DJIA) had a volatile ride this past week, due to several factors. Comments from Jerome Powell (the Chair of the U.S. Federal Reserve), GDP forecasting, unemployment rate (and jobless claims) data, and coronavirus pandemic data all played their own significant parts in the DJIA activity. The …

GDP Contraction, the Fed, and the Dow Jones – Week of April 27 – May 1, 2020

By Kuldip K. Ambastha The Dow Jones had three down and two up days this week. The coronavirus pandemic has continued to wreak havoc all around the world, and the American capital markets were affected. During 1Q2020, the USA’s GDP (gross domestic product) annualized contraction rate was 4.8%. This figure was announced on Wednesday, April …

Jobs, Unemployment, and the Dow Jones – Week of March 30 – April 3, 2020

By Kuldip K. Ambastha The Dow Jones was up and down this week day by day, similar to what has been seen in the past few weeks. Due to the coronavirus pandemic and its related public health concerns around the world, massive changes have been seen in the USA and these changes have been affecting …